Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berardi

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Medicinal Chemistry|August 2, 1996
1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3R Perrone, F Berardi, M Leopoldo, et al.
Haematologica|January 1, 1992
Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomasM De Lena, A Barletta, F Marzullo, et al.
Haematologica|July 1, 1993
Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy)M De Lena, P Ditonno, V Lorusso, et al.
Journal of Medicinal Chemistry|January 7, 1994
Mixed 5-HT1A/D-2 activity of a new model of arylpiperazines: 1-aryl-4-[3-(1,2-dihydronaphthalen-4-yl)-n-propyl]piperazines. 1. Synthesis and structure-activity relationshipsR Perrone, F Berardi, N A Colabufo, et al.
Tumori|June 30, 1993
M-VECA (methotrexate, vinblastine, epidoxorubicin and carboplatin) in the treatment of advanced urothelial carcinomaV Lorusso, F Berardi, M Brandi, et al.
Journal of Medicinal Chemistry|December 6, 1996
Structure-activity relationship studies on the 5-HT(1A) receptor affinity of 1-phenyl-4-[omega-(alpha- or beta-tetralinyl)alkyl]piperazines. 4R Perrone, F Berardi, N A Colabufo, et al.
Journal of Medicinal Chemistry|March 17, 1995
High affinity and selectivity on 5-HT1A receptor of 1-aryl-4-[1-tetralin)alkyl]piperazines. 2R Perrone, F Berardi, N A Colabufo, et al.
Journal of Medicinal Chemistry|December 1, 2001
trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazinesR Perrone, F Berardi, N A Colabufo, et al.
Nuclear Medicine and Biology|January 11, 2001
Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomographyO Langer, C Halldin, Y Chou, et al.
International Journal of Oncology|May 17, 2011
Fec (Fluorouracil, epirubicin, cyclophosphamide) plus granulocyte macrophage-colony-stimulating factor (gm-csf) in advanced or inflammatory breast-cancer - a dose-finding studyV Lorusso, C Tatulli, F Berardi, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Medicinal Chemistry|August 2, 1996
1-aryl-4-[(1-tetralinyl)alkyl]piperazines: alkylamido and alkylamino derivatives. Synthesis, 5-HT1A receptor affinity, and selectivity. 3R Perrone, F Berardi, M Leopoldo, et al.
Haematologica|January 1, 1992
Prognostic relevance of ploidy and proliferative activity evaluation by flow cytometry in poor prognosis non-Hodgkin's lymphomasM De Lena, A Barletta, F Marzullo, et al.
Haematologica|July 1, 1993
Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy)M De Lena, P Ditonno, V Lorusso, et al.
Journal of Medicinal Chemistry|January 7, 1994
Mixed 5-HT1A/D-2 activity of a new model of arylpiperazines: 1-aryl-4-[3-(1,2-dihydronaphthalen-4-yl)-n-propyl]piperazines. 1. Synthesis and structure-activity relationshipsR Perrone, F Berardi, N A Colabufo, et al.
Tumori|June 30, 1993
M-VECA (methotrexate, vinblastine, epidoxorubicin and carboplatin) in the treatment of advanced urothelial carcinomaV Lorusso, F Berardi, M Brandi, et al.
Journal of Medicinal Chemistry|December 6, 1996
Structure-activity relationship studies on the 5-HT(1A) receptor affinity of 1-phenyl-4-[omega-(alpha- or beta-tetralinyl)alkyl]piperazines. 4R Perrone, F Berardi, N A Colabufo, et al.
Journal of Medicinal Chemistry|March 17, 1995
High affinity and selectivity on 5-HT1A receptor of 1-aryl-4-[1-tetralin)alkyl]piperazines. 2R Perrone, F Berardi, N A Colabufo, et al.
Journal of Medicinal Chemistry|December 1, 2001
trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazinesR Perrone, F Berardi, N A Colabufo, et al.
Nuclear Medicine and Biology|January 11, 2001
Carbon-11 pb-12: an attempt to visualize the dopamine d(4) receptor in the primate brain with positron emission tomographyO Langer, C Halldin, Y Chou, et al.
International Journal of Oncology|May 17, 2011
Fec (Fluorouracil, epirubicin, cyclophosphamide) plus granulocyte macrophage-colony-stimulating factor (gm-csf) in advanced or inflammatory breast-cancer - a dose-finding studyV Lorusso, C Tatulli, F Berardi, et al.
Pageof 5